Find Therapeutics accueille deux nouveaux membres à son conseil d'administration
Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101
Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101